Source:http://linkedlifedata.com/resource/pubmed/id/10383630
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1999-7-30
|
pubmed:abstractText |
Episodic ataxia type 1 (EA-1) is a rare neurological disorder and was the first ionic channel disease to be associated with defects in a potassium channel. Until now 10 different point mutations in the KCNA1-gene have been reported to cause this disorder. We have investigated the functional consequences of two mutations leading to amino acid substitutions in the first and sixth transmembrane segments of a Kv1.1 channel subunit, by means of the patch-clamp technique; we injected cRNA coding for, respectively, F184C and V408A mutant Kv1.1 channels into mammalian cells and compared the resulting currents with those in the wild-type. The expression levels of F184C and V408A mutant channels relative to that of the wild-type was 38 and 68%, respectively. Since the single-channel conductance of the F184C mutant was similar to that of the wild-type (12 pS) without an apparent change in the maximum open probability, we conclude that the lower expression level in the F184C mutant channels is due to a reduced number of functional channels on the cell surface. F184C activated slower, and at more depolarized potentials, and deactivated faster compared with the wild-type. V408A channels deactivated and inactivated faster compared with the wild-type. Studies with different extracellular cations and tetraethylammonium gave no indication that the pore structure was changed in the mutant channels. Acetazolamide, that is helpful in some patients suffering from EA-1, was without effect on Kv1.1 wild-type or mutant channels. This study confirms and extends earlier studies on the functional consequences of Kv1.1 mutations associated with EA-1, in an attempt to understand the pathophysiology of the disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetazolamide,
http://linkedlifedata.com/resource/pubmed/chemical/Kv1.1 Potassium Channel,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, Voltage-Gated,
http://linkedlifedata.com/resource/pubmed/chemical/Tetraethylammonium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0953-816X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2403-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10383630-Acetazolamide,
pubmed-meshheading:10383630-Animals,
pubmed-meshheading:10383630-Ataxia,
pubmed-meshheading:10383630-Electric Conductivity,
pubmed-meshheading:10383630-Electrophysiology,
pubmed-meshheading:10383630-Kv1.1 Potassium Channel,
pubmed-meshheading:10383630-Mutation,
pubmed-meshheading:10383630-Potassium Channel Blockers,
pubmed-meshheading:10383630-Potassium Channels,
pubmed-meshheading:10383630-Potassium Channels, Voltage-Gated,
pubmed-meshheading:10383630-Rats,
pubmed-meshheading:10383630-Tetraethylammonium,
pubmed-meshheading:10383630-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1).
|
pubmed:affiliation |
Department of Applied Physiology, University of Ulm, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|